TECH
$198.98
Bio-Techne Cp
$.38
.19%
TECH
Earnings Whisper ®
N/A
1st Quarter September 2018
Consensus:  $0.88
Revenue:  $160.19 Mil
Tuesday
Nov 6
7:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS
Tuesday, August 7, 2018

What do you expect when TECH reports earnings?
Beat
Meet
Miss

Where is TECH's stock price going from here?
Up
Flat
Down
Stock chart of TECH
Analysts
Summary of analysts' recommendations for TECH
Score
Grade
Pivots
Resistance
$202.79
$201.21
$200.10

$198.52

Support
$197.40
$195.82
$194.71
Tweet
Growth
Description
Bio-Techne Corporation is a global life sciences company. It develops, manufactures, and sells biotechnology products and clinical diagnostic controls. It provides proteins, such as cytokines, growth factors, and enzymes; antibodies, including polyclonal and monoclonal antibodies; immunoassays comprising quantikine kits; and clinical diagnostic immunoassay kits. The Company also offers flow cytometry products; natural and synthetic chemical compounds; hematology controls and calibrators; and hematology control products. Bio-Techne Corporation, formerly known as Techne Corporation, is headquartered in Minneapolis, Minnesota.
Peers
BiogenGilead SciencesBluebird BioAmgenNeurocrine BiosciencesSeattle GeneticsBioCryst PharmaceuticalsQiagen N.V.NovavaxRepligen